Latest filing published 04 Jun 2021 for Allakos Inc., €180k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Henrik S. Rasmussen MD is a declared insider at 3 companies (senior executive); the most frequent names are Allakos Inc., Vaxart, Inc. and ZS Pharma, Inc. We count 23 filings; the first trade dates from 24 February 2006 and the latest from 4 June 2021.
On the market, this insider has only sold: 8 sales, €11.0M in total. Besides market trades, the filings include 7 share grants and 6 option exercises. In 2021 alone, the filings show no purchases and 8 sales.
Most recently, on 4 June 2021, the filings show a share grant worth €63k in Allakos Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration